loading

United Therapeutics Corp Borsa (UTHR) Ultime notizie

pulisher
Sep 27, 2026

United Therapeutics Corporation (UTHR) stock price, news, quote and history - Yahoo Finance Australia

Sep 27, 2026
pulisher
Sep 26, 2026

Form 4 United Therapeutics Corporation For: 26 September By Investing.com - Investing.com Nigeria

Sep 26, 2026
pulisher
Sep 26, 2026

United Therapeutics chairperson & CEO sells $4.7m in stock - Investing.com

Sep 26, 2026
pulisher
Sep 26, 2026

United Therapeutics chairperson & CEO sells $4.7m in stock By Investing.com - ng.investing.com

Sep 26, 2026
pulisher
Sep 26, 2026

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits

Sep 26, 2026
pulisher
Sep 25, 2026

After exercising stock options, the CEO's family trust sold 9,500 United Therapeutics (UTHR) shares. - Stock Titan

Sep 25, 2026
pulisher
Sep 25, 2026

United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions - Yahoo Finance

Sep 25, 2026
pulisher
Sep 25, 2026

UTHR News | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill

Sep 25, 2026
pulisher
Sep 24, 2026

Why United Therapeutics (UTHR) Shares Are Falling Today - Yahoo Finance

Sep 24, 2026
pulisher
Sep 24, 2026

United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 24, 2026
pulisher
Sep 24, 2026

A Look at United Therapeutics Corp (UTHR) After 3.5% Decline -- GF Value $427.97 vs Price $472.21 - gurufocus.com

Sep 24, 2026
pulisher
Sep 24, 2026

United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise - Investing.com Nigeria

Sep 24, 2026
pulisher
Sep 24, 2026

Form 4 United Therapeutics Corporation For: 24 September - Investing.com India

Sep 24, 2026
pulisher
Sep 24, 2026

Form 4 United Therapeutics Corporation For: 24 September By Investing.com - Investing.com Canada

Sep 24, 2026
pulisher
Sep 24, 2026

After exercising 9,500 options, family trusts sold United Therapeutics (UTHR) shares under a pre-arranged plan. - Stock Titan

Sep 24, 2026
pulisher
Sep 24, 2026

United Therapeutics Falls as Goldman Sachs Sets $321 Price Target - citybiz

Sep 24, 2026
pulisher
Sep 24, 2026

United Therapeutics, Sagimet drop as Goldman issues Sell (UTHR) - Seeking Alpha

Sep 24, 2026
pulisher
Sep 24, 2026

United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate - ChartMill

Sep 24, 2026
pulisher
Sep 24, 2026

Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com - Investing.com Australia

Sep 24, 2026
pulisher
Sep 24, 2026

Goldman Sachs initiates United Therapeutics stock with sell rating - Investing.com

Sep 24, 2026
pulisher
Sep 23, 2026

Under a pre-arranged plan, United Therapeutics (UTHR) CEO’s family trusts exercise 9,500 options and sell the shares. - Stock Titan

Sep 23, 2026
pulisher
Sep 23, 2026

United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth (NASDAQ:UTHR) - Seeking Alpha

Sep 23, 2026
pulisher
Sep 23, 2026

United Therapeutics Corporation at Bernstein Healthcare Forum Transcript - gurufocus.com

Sep 23, 2026
pulisher
Sep 22, 2026

United Therapeutics CEO Rothblatt sells $4.7m in stock By Investing.com - Investing.com Australia

Sep 22, 2026
pulisher
Sep 22, 2026

United Therapeutics CEO Rothblatt sells $4.7m in stock - Investing.com

Sep 22, 2026
pulisher
Sep 22, 2026

United Therapeutics Insider Sold Shares Worth $4,698,271, According to a Recent SEC Filing - marketscreener.com

Sep 22, 2026
pulisher
Sep 22, 2026

United Therapeutics (UTHR) CEO sells shares at nearly $500 each - Stock Titan

Sep 22, 2026
pulisher
Sep 22, 2026

United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com - Investing.com Nigeria

Sep 22, 2026
pulisher
Sep 22, 2026

Form 4 United Therapeutics Corporation For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026
pulisher
Sep 22, 2026

United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares - Investing.com

Sep 22, 2026
pulisher
Sep 21, 2026

CEO stock sale near $500 a share was preplanned, United Therapeutics (UTHR) says - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

United Therapeutics (NASDAQ:UTHR) Screens as a High-Quality, Debt-Free Stock - ChartMill

Sep 21, 2026
pulisher
Sep 18, 2026

United Therapeutics EVP Paul A. Mahon Executes Stock Options and Sells Shares Under 10b5-1 Plan - kalkinemedia.com

Sep 18, 2026
pulisher
Sep 18, 2026

United Therapeutics (UTHR) CEO sells 9,500 shares under preset plan - Stock Titan

Sep 18, 2026
pulisher
Sep 18, 2026

United Therapeutics (NASDAQ: UTHR) general counsel sells shares near $500 - Stock Titan

Sep 18, 2026
pulisher
Sep 17, 2026

United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options and sells matching shares - Stock Titan

Sep 17, 2026
pulisher
Sep 16, 2026

United Therapeutics (NASDAQ: UTHR) CEO exercises options and sells stock under preset plan - Stock Titan

Sep 16, 2026
pulisher
Sep 15, 2026

Director Nilda Mesa Sells 228 Shares of United Therapeutics Corp (UTHR) - GuruFocus

Sep 15, 2026
pulisher
Sep 15, 2026

United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options, then sells the shares under preset plan - Stock Titan

Sep 15, 2026
pulisher
Sep 15, 2026

United Therapeutics (UTHR) director exercises options, then sells shares - Stock Titan

Sep 15, 2026
pulisher
Sep 14, 2026

United Therapeutics CEO Martine Rothblatt sells $4.7m in shares By Investing.com - Investing.com Nigeria

Sep 14, 2026
pulisher
Sep 14, 2026

United Therapeutics Corporation at Morgan Stanley Global Healthcare Conference Transcript - gurufocus.com

Sep 14, 2026
pulisher
Sep 14, 2026

United Therapeutics CEO Martine Rothblatt sells $4.7m in shares - Investing.com

Sep 14, 2026
pulisher
Sep 11, 2026

United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Zacks Investment Research

Sep 11, 2026
$18.27
price up icon 2.47%
$140.44
price up icon 1.47%
ZTS ZTS
$71.43
price up icon 0.53%
$22.45
price up icon 0.63%
RDY RDY
$12.51
price up icon 2.12%
Capitalizzazione:     |  Volume (24 ore):